(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...

CARLSBAD, California - Palisade Bio, Inc. (NASDAQ:PALI), a $193 million market cap biotech company, announced Monday that the Canadian Intellectual Property Office has granted patent number 3,174,137 ...

The World Health Organization sounded the alarm Monday about a growing threat of drug-resistant bacteria around the globe that could undermine life-saving treatments, an issue Wayne State University ...

FLINT, MI -- The City Council has rejected an ordinance that called for drug testing of elected officials after a city attorney warned it was “fraught with lots of problems.” All seven council members ...

One in six common bacterial infections diagnosed worldwide in 2023 were resistant to treatment with antibiotics, according to the latest surveillance data gathered by the World Health Organization ...

The US Food and Drug Administration is reviewing evidence about the safety and efficacy of one of the drugs used in medication abortion to investigate how it can be safely dispensed, US Health and ...

SEOUL, Oct. 14 (UPI) --South Korea's Hyundai ADM Bio said Tuesday that its new cancer drug under development, Penetrium, also may prove effective treating such diseases as rheumatoid arthritis and ...

Cabaletta Bio’s CAR-T cell therapy has eliminated the overreactive B cells of two patients with an autoimmune disease without preconditioning chemotherapy, pleasing investors and analysts while ...

Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women's health, today announced the close of a £5M pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, ...